Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Recent high-throughput pharmacogenomic studies have deepened our understanding of the molecular players in this human-microbiota relationship
The completed AWARD phase 3 trials showed that dulaglutide 1.5 mg leads to a superior reduction in HbA1c compared to exenatide and sitagliptin once weekly after 26 weeks
Clinical trials involving over 10,000 participants did not show increased nodule incidence
Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice
Call and ask, we likely cover it
US$ 22.22
US$ 27.02
US$ 28.22
US$ 25.21
